Skip to main content
Georgia Public Broadcasting Logo
  • TV
  • Radio
  • News

    Featured Programs & Series

    • Political Rewind
    • Battleground: Ballot Box
    • 1A
    • Lawmakers
    • What You Need to Know: Coronavirus
    • Southern Reading List
    • Powering Georgia
    • Food Access

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Coronavirus
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Contact GPB News
    • Follow Us on Apple News
  • Education

    Browse by Subject

    • CTAE
    • English Language Arts
    • Mathematics
    • Physical Health and Wellness
    • Professional Learning
    • STEAM
    • Science
    • Social Studies
    • The Arts
    • World Languages

    Browse by Grade

    • Preschool-PreK
    • K-2
    • 3-5
    • 6-8
    • 9-12

    Featured

    • Classroom Conversations Podcast
    • Georgia Studies Collection
    • Make That Paper!
    • VR in the Classroom
    • Lights, Camera, Budget!
    • Georgia Home Classroom
    • Chemistry Matters
    • Physics in Motion
    • Virtual Field Trips
    • Writers Contest
    • PBS LearningMedia
    • PBS KIDS
  • Sports
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Family

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Family Blog
    • Kids & Family Events
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live
GPB News

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Politics
  • Lawmakers
  • Battleground: Ballot Box

Don't Miss

Don't Miss:

  • Election Updates and Results
  • TV Highlights This Week
  • Get GPB's Political newsletter

News Articles: pfizer

Finn Washburn, 9, receives an injection of the Pfizer-BioNTech COVID-19 vaccine in San Jose, Calif., in November. Now the pharmaceutical companies are seeking authorization to give kids a booster dose of the vaccine.

Tagged as: 

  • Health

Pfizer asks FDA to authorize booster shots for kids ages 5 through 11

Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.

April 26, 2022
|
By:
  • Rob Stein
A health care worker prepares the current COVID vaccine booster shots from Moderna in February. The company says a bivalent vaccine that combines the original strain with the omicron strain is the lead candidate for a fall vaccination campaign.

Tagged as: 

  • Health

Moderna says its new 'bivalent' vaccine shows promise against COVID variants

The company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.

April 19, 2022
|
By:
  • Rob Stein
A staff member poses with a vial of Pfizer-BioNTech COVID-19 vaccine at a vaccination health center.

Tagged as: 

  • Health

Pfizer-BioNTech will seek authorization for second COVID booster for older adults

Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.

March 15, 2022
|
By:
  • Scott Hensley
A medical worker prepares the Pfizer-BioNTech Covid-19 vaccine booster in Hartford, Connecticut, in January.

Tagged as: 

  • Health

The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids

"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," FDA officials said in a statement.

February 11, 2022
|
By:
  • Scott Hensley
Paxlovid tablets are packaged at a Pfizer factory in Italy.

Tagged as: 

  • Health

Feds' contract with Pfizer for Paxlovid has some surprises

NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

February 02, 2022
|
By:
  • Sydney Lupkin
With its new COVID-19 vaccine, Pfizer and BioNTech are hoping to get ahead of worsening effects of omicron as well as any new variants.

Tagged as: 

  • Health

Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine

Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide.

January 25, 2022
|
By:
  • Joe Hernandez
A resident receives a dose of the Pfizer COVID-19 vaccine at a health center in Jakarta, Indonesia, on Jan. 13. This week, Indonesia started a program to give booster shots to the elderly and people at risk of severe disease.

Tagged as: 

  • Global Health

Booster longevity: Data reveals how long a third shot protects

Researchers in the U.K. have the first estimates for how long a third shot of the Pfizer vaccine will last. The findings are mixed.

January 20, 2022
|
By:
  • Michaeleen Doucleff
Pfizer's antiviral pill Paxlovid was authorized to treat COVID-19, by the Food and Drug Administration on Wednesday.

Tagged as: 

  • Health

FDA authorizes 1st antiviral pill for COVID

In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.

December 22, 2021
|
By:
  • Scott Hensley
Fever is a possible side effect of a COVID19 vaccine.

Tagged as: 

  • Global Health

Coronavirus FAQ: What does it mean if the booster knocks me out? What if it doesn't?

Vaccine and booster side effects can include fever, aches and fatigue. And this may be the first vaccine in history where people complain if they don't experience side effects, says one doctor.

December 10, 2021
|
By:
  • Sheila Mulrooney Eldred
Here's a computer-generated image of the omicron variant of the coronavirus — also known as B.1.1.529. Reported in South Africa on Nov. 24, this variant has a large number of mutations, some of which are concerning.

Tagged as: 

  • Global Health

Studies suggest sharp drop in vaccine protection vs. omicron — yet cause for optimism

In small studies in South Africa and in Germany, the results indicate a marked decrease in the ability of vaccines to neutralize this variant. But there are other findings that are encouraging.

December 08, 2021
|
By:
  • Michaeleen Doucleff
People line up outside a free COVID-19 vaccination site that opened Friday in Washington, D.C. The local health department is stepping up vaccination and booster shots as more cases of the omicron variant are being identified in the United States.

Tagged as: 

  • Health

Omicron boosters are in the works, but will they be needed?

Omicron has many more mutations than previous variants of concern, a fact that raises questions about how effective existing vaccines will be against the new form of the coronavirus.

December 07, 2021
|
By:
  • Sydney Lupkin
Scientists at Pfizer's research and development laboratories in Groton, Conn., worked on the COVID-19 pill called Paxlovid.

Tagged as: 

  • Health

How Pfizer developed a COVID pill in record time

Pfizer researchers looking for a drug to treat SARS found clues that gave the company a head start in its quest for a pill to treat COVID-19, including the omicron variant.

December 03, 2021
|
By:
  • Joe Palca
Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-year-olds.

Tagged as: 

  • Health

Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot

Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.

November 30, 2021
|
By:
  • Will Stone
Molnupiravir, an antiviral drug to treat mild to moderate COVID-19, is under consideration by an FDA advisory panel for possible authorization.

Tagged as: 

  • Health

New antiviral drugs are coming for COVID. Here's what you need to know

The FDA is considering new pills that could treat people in early stages of COVID. Here's what to know about how they work, how effective they are and the impact they could make on the pandemic.

November 30, 2021
|
By:
  • Pien Huang
Nurse Sandra Lindsay celebrates after receiving her COVID-19 Pfizer vaccine booster at Long Island Jewish Medical Center in New York in October. Lindsay was the first person known to receive a COVID vaccine in the United States vaccination campaign — on Dec. 14, 2020. Her vaccination card is displayed at the COVID-19 exhibit in the Smithsonian Museum of American History.

Tagged as: 

  • Global Health

Coronavirus FAQ: I just got a booster. Can I ... go crazy?

Does a booster shot mean that you can go back to ... normal? Or is there still a newish kind of normal to face?

November 13, 2021
|
By:
  • Sheila Mulrooney Eldred
  • Load More

Newsletter Signup

Sign Up For Our Newsletter

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • TV
  • Radio
  • News
  • Education
  • Sports
  • Events
  • Kids & Family
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletter

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2022, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®